Solid tumour
Information
- Disease name
- Solid tumour
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02086721 | Completed | Phase 1 | Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor | December 2015 | May 2017 |
| NCT02648490 | Completed | Phase 1 | An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers | September 2016 | June 28, 2019 |
| NCT04958226 | Completed | Phase 1 | A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours | October 15, 2021 | February 15, 2023 |
| NCT01300468 | Completed | Phase 1 | Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors | April 2006 | December 2009 |
| NCT01447732 | Completed | Phase 1 | Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors | October 2011 | January 2015 |
| NCT01489826 | Completed | Phase 1 | A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours | January 2012 | July 2015 |
| NCT04121910 | Completed | Phase 1 | A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole | November 7, 2019 | January 12, 2020 |
| NCT01627990 | Completed | Nivestim™ in Treatment of Malignant Diseases | June 2011 | December 2013 | |
| NCT01516645 | Terminated | Phase 1 | Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors | January 2012 | May 2015 |
| NCT01219543 | Terminated | Phase 1 | A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. | November 2010 | December 2012 |
| NCT01046461 | Unknown status | Phase 2 | Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer | January 2010 | June 2012 |
| NCT01226407 | Unknown status | Phase 1 | Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile | September 2010 | February 2013 |
| NCT04891718 | Withdrawn | Early Phase 1 | CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia | September 15, 2021 | June 5, 2022 |